-
dBRD9 is a PROTAC (proteolysis targeting chimera) and can be used as a selective valuable probe for degrading BRD9.
-
MC0704 is a STAT3 inhibitor (IC50=2.13 μM), which can be used for the research of metastatic triple-negative breast cancer (mTNBC).
-
Palbociclib is a potent, selective and orally active CDK4 and CDK6 inhibitor with strong anti-cancer activity.
-
Dazostinag is a STING agonist and a playload, to synthesis antibody-drug conjugates (ADCs). It has antitumor activity in vivo.
-
Sotorasib is a first-in-class, orally bioavailable, and selective KRAS G12C covalent inhibitor, which inhibits tumor growth in mice.
-
SU056 is a YB-1 inhibitor that induces cell cycle arrest, apoptosis and inhibits cell migration of cancer cells.
-
Cetuximab is a potent human anti-EGFR monoclonal antibody. Besides, Cetuximab also shows anti-tumor activity.
-
SG-094 is a potent TPC2 inhibitor with antiproliferative effects. SG-094 can be used for the research of cancer.
-
SH-BC-893 is an orally active sphingolipid analog. It can be used for the research of cancer and metabolism-related diseases.
-
RLA-5331 is an iron activator containing anti-androgen. RLA-5331 is used for metastatic castrated tolerant prostate cancer (mCRPC) research.
Categories
Diseases
Others
Archives
- March 2023 (8)
- February 2023 (10)
- January 2023 (6)
- December 2022 (11)
- November 2022 (5)
- October 2022 (11)
- September 2022 (7)
- August 2022 (9)
- July 2022 (9)
- June 2022 (11)
- May 2022 (10)
- April 2022 (5)
- March 2022 (2)
- February 2022 (3)
- January 2022 (4)
- December 2021 (3)
- November 2021 (3)
- October 2021 (1)
- August 2021 (7)
- July 2021 (2)
- June 2021 (1)
- May 2021 (5)
- April 2021 (5)
- March 2021 (4)
- February 2021 (2)
- January 2021 (4)
- December 2020 (3)
- November 2020 (4)
- October 2020 (5)
- September 2020 (3)
- August 2020 (4)
- June 2020 (3)
- May 2020 (3)
- April 2020 (3)
- March 2020 (5)
- February 2020 (2)
- January 2020 (5)
- December 2019 (2)
- November 2019 (1)
- October 2019 (2)
- September 2019 (7)
- August 2019 (7)
- July 2019 (10)
- June 2019 (4)
- May 2019 (6)
- April 2019 (4)